$3.6 Million to Study Adverse Effects of Genome EditingNews
As genome editing technologies advance toward clinical therapies, they are raising hopes of a completely new way to treat disease. However, challenges need to be addressed before potential treatments can be widely used in patients. To tackle these challenges, the National Institutes of Health has launched the Somatic Cell Genome Editing program, which has awarded multiple grants including more than $3.6 million to assess the safety of genome editing in human cells and tissues.
Exploiting Epigenetic Variation for Plant BreedingNews
Plant biologists at the University of Zurich have now demonstrated that epigenetic variation is also subject to selection and can be inherited. This could expand the possibilities for crop breeding.READ MORE
Studying the 3D of DNA and its dynamics is revealing a lot of information about gene expression, expanding our knowledge of how cells, tissues and organs actually work in health and disease. Properly producing and managing this large amount of data is both challenging and necessary for the progress of this field. In a perspective paper published in Nature Genetics, researchers call for unified standards and suggest guidelines in this emerging and promising research area.READ MORE
The future looks challenging for plants. Climate change is forecast to bring widespread drought to parts of the planet already struggling with dry conditions. To mitigate the potentially devastating effects to agriculture, researchers are seeking strategies to help plants withstand extreme environmental hazards.READ MORE
There are many ways to slice and dice genomic data to identify a species of bacteria, or at least find its close relatives. But fast techniques to sequence genomes have flooded the public databases and in a biased fashion, containing lots of genomic data about some species and not enough about others, according to a Rice University computer scientist.
A kill code is embedded in every cell in the body whose function may be to cause the self-destruction of cells that become cancerous, reports a new Northwestern Medicine study.READ MORE
New method increases the released lentiviral particles produced by host cells, which will aid the use of the vectors for introducing foreign genes.READ MORE
A drug could help slow the progression of some advanced ovarian cancers and extend the time that patients show no signs of disease, according to new clinical trial results.